Increase of ciprofloxacin resistance in Campylobacter species in Styria, Austria

Feierl, Gebhard; Pschaid, Andrea; Sixl, Birgit; Marth, Egon

doi:10.1016/s0934-8840(11)80333-6

Cited by 10 publications

(4 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Use of these drugs for infections other than gastroenteritis and self-medication are often the causes of resistance in developing countries; in developed countries, resistance is due to their use in food animals and travel to developing countries. The increase in erythromycin resistance in developed countries is often low and stable at approximately 1% to 2%; this is not true for developing countries ( 41 , 42 ). For example, in 1984, 82% of Campylobacter strains from Lagos, Nigeria, were sensitive to erythromycin; 10 years later, only 20.8% were sensitive ( 17 ) .…”

Section: Antibiotic Resistance In Campylobacter Ismentioning

confidence: 99%

See 1 more Smart Citation

Human Campylobacteriosis in Developing Countries1

Coker

Isokpehi²,

Thomas³

et al. 2002

Emerg. Infect. Dis.

442

364

View full text Add to dashboard Cite

Campylobacteriosis is a collective description for infectious diseases caused by members of the bacterial genus Campylobacter. The only form of campylobacteriosis of major public health importance is Campylobacter enteritis due to C. jejuni and C. coli. Research and control efforts on the disease have been conducted more often in developed countries than developing countries. However, because of the increasing incidence, expanding spectrum of infections, potential of HIV-related deaths due to Campylobacter, and the availability of the complete genome sequence of C. jejuni NCTC 11168, interest in campylobacteriosis research and control in developing countries is growing. We present the distinguishing epidemiologic and clinical features of Campylobacter enteritis in developing countries relative to developed countries. National surveillance programs and international collaborations are needed to address the substantial gaps in the knowledge about the epidemiology of campylobacteriosis in developing countries.

show abstract

Section: Antibiotic Resistance In Campylobacter Ismentioning

confidence: 99%

“…In Thailand, ciprofloxacin resistance among Campylobacter species increased from zero before 1991 to 84% in 1995 ( 43 ) . Recent data have shown a marked increase in resistance to quinolones in developed countries ( 41 , 42 , 44 – 46 ) ( Table 4 ).…”

Section: Antibiotic Resistance In Campylobacter Ismentioning

confidence: 99%

Human Campylobacteriosis in Developing Countries1

Coker

Isokpehi²,

Thomas³

et al. 2002

Emerg. Infect. Dis.

442

364

View full text Add to dashboard Cite

show abstract

“…isolates to ciprofloxacin increased from 0 % in 1988 to 34 . 1% in 1997 [7][8][9]. Several researchers attribute this pattern to the introduction of quinolones in poultry production [10,11].…”

Section: Introductionmentioning

confidence: 99%

Campylobacter jejuni isolated from poultry and humans in Styria, Austria: epidemiology and ciprofloxacin resistance

Hein

Schneck²,

Knögler³

et al. 2003

Epidemiol. Infect.

View full text Add to dashboard Cite

Sixty-six broiler flocks were sampled to determine the presence of Campylobacter spp. at slaughter in 1998. Thirty flocks (45 %) tested positive and C. jejuni was identified in all isolates. Combined pulsed-field gel electrophoresis/amplified fragment length polymorphism (PFGE/ AFLP) subtyping of 177 isolates from 24 positive flocks revealed 62 subtypes ; 16 flocks harboured more than one subtype. When subtyping 101 clinical C. jejuni isolates collected in the same time period and area, 60 PFGE/AFLP types were identified. Comparison of subtypes from poultry and human isolates revealed three shared PFGE/AFLP types, which were present in 11 human isolates. Fifty per cent of all poultry isolates and 39% of all human isolates were resistant to ciprofloxacin. The present study confirms the increase in ciprofloxacin resistance in both human and poultry C. jejuni isolates in Austria, as observed in several countries worldwide. A small number of human isolates shared PFGE/AFLP types with poultry isolates, however, further studies should also focus on the identification of other sources of C. jejuni infection in humans.

show abstract

“…In contrast, the restricted use of fluoroquinolones in food-producing animals in Australia is associwkw 3-4/2009 Campylobacteriosis in Austria: situation and trends review article 106 ated with a very low frequency of resistance to this class of antibiotics in domestically acquired campylobacteriosis [23]. Similarly, no quinolone and macrolide resistance was observed in Austria in 1988, but a clear and steady increase in quinolone resistance was observed in the following years [24][25][26] (Fig. 2).…”

Section: Antimicrobial Resistancementioning

confidence: 99%

Campylobacteriosis in Austria: situation and trends

Feierl

Jelovcan

2009

Wien Klin Wochenschr

Self Cite

View full text Add to dashboard Cite

Campylobacter species are among the most commonly identified causative agents of acute bacterial gastroenteritis in humans worldwide. In Austria, campylobacteriosis has been a notifiable disease since 1996 and its incidence has increased continuously over the past years. Improvement of notification has led to an important increase in knowledge of the epidemiology of this disease in Austria. In addition to existing programs monitoring food safety, implementation of a national surveillance program to monitor antimicrobial resistance and the prevalence of campylobacter in food animals allows continuous surveillance of trends in antimicrobial susceptibility patterns in humans, animals and food, as well as a more comprehensive evaluation of the occurrence of campylobacter in the relevant reservoirs of human infection. Such data make it possible to identify the most important areas for intervention and launch of control strategies. As in other countries around the world, antimicrobial resistance of campylobacter from human, animal and food origin, particularly resistance to fluoroquinolones, is of public health concern in Austria. The magnitude of global trade and foreign travel requires EU-wide and worldwide implementation of control strategies to fight campylobacteriosis.

show abstract

Increase of ciprofloxacin resistance in Campylobacter species in Styria, Austria

Cited by 10 publications

References 13 publications

Human Campylobacteriosis in Developing Countries1

Human Campylobacteriosis in Developing Countries1

Campylobacter jejuni isolated from poultry and humans in Styria, Austria: epidemiology and ciprofloxacin resistance

Campylobacteriosis in Austria: situation and trends

Contact Info

Product

Resources

About